AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimefide M 2 FT Tablet

Prescription Icon
Prescription Required

Marketer

Fidelity Lifesciences Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Glimefide M 2 FT Tablet

Diabetic patients often benefit from Glimefide M 2 FT Tablets, a dual-action antidiabetic medication. This formulation combines two agents to effectively manage type 2 diabetes in adults by regulating blood glucose. Consistent daily dosing, ideally with meals, maximizes therapeutic efficacy. Dosage adjustments are determined by your physician based on your individual response and blood sugar monitoring. Discontinuing this medication without medical supervision is risky and can lead to uncontrolled blood sugar, potentially causing kidney complications, vision impairment, neurological issues, and limb loss. Therefore, continued use, even with controlled blood sugar, remains crucial. This medicine is only one element of a comprehensive diabetes management plan, which should include a doctor-recommended diet, exercise regimen, and weight management strategy. Commonly, Glimefide M 2 FT Tablets can cause hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, lightheadedness, headaches, and tremors. Maintain regular meals and always carry a readily available fast-acting glucose source, such as juice or candy. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before using this medicine if you are pregnant or breastfeeding. Routine blood glucose monitoring is essential, and supplementary blood tests for blood cell counts and liver function may be recommended by your healthcare provider.

Uses of Glimefide M 2 FT Tablet

Managing type 2 diabetes

Major Benefits of Glimefide M 2 FT Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimefide M 2 FT Tablet with a meal.

Common Side effects of Glimefide M 2 FT Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimefide M 2 FT Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimefide M 2 FT Tablet should be administered with a meal.

How Glimefide M 2 FT Tablet works:

Glimefide M 2 FT Tablet combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimefide M 2 FT Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimefide M 2 FT Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimefide M 2 FT Tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimefide M 2 FT Tablets, potentially requiring dosage modification. Consult a physician for guidance. Glimefide M 2 FT Tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimefide M 2 FT Tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Glimefide M 2 FT Tablet :

Should you forget a Glimefide M 2 FT Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimefide M 2 FT Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimefide M 2 FT Tablet

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimefide M 2 FT Tablet use can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimefide M 2 FT Tablet and seek immediate medical attention.
Glimefide M 2 FT Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimepiride tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimepiride M 2 FT Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimepiride M 2 FT Tablets can cause low blood sugar (hypoglycemia), with symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimepiride M 2 FT Tablet and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Glimefide M 2 FT Tablet
66
MRP 81
18% off